TSRO News Alert Tesaro Inc (TSRO) 34.36 12/17/2014 02:50:12

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tesaro Inc (TSRO) 34.36 $TSRO

Pfizer Licenses Opko's Long-Acting Growth Hormone
at Investor's Business Daily - Mon Dec 15, 11:01AM CST
Biotech Opko Health found a big-pharma partner for its human-growth drug candidate in the form of Pfizer on Monday in a deal that could be worth as much as $570 million. Opko Health (OPK) stock was near 9, up 9% in morning trading -- a more than...
TSRO: 34.36 (+0.32), OPK: 8.70 (-0.16), PFE: 30.67 (-0.19)

RedHill submits MAA for ondansetron
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:38AM CST

INSY: 41.31 (+0.23), TSRO: 34.36 (+0.32), HRTX: 9.06 (-0.01), RDHL: 10.75 (-1.41), GWPH: 67.64 (-0.49), OPK: 8.70 (-0.16), GALE: 1.53 (-0.10)

TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate
GlobeNewswire - Tue Dec 02, 4:14AM CST
--Candidate Will Target Two Undisclosed Immune Checkpoints
TSRO: 34.36 (+0.32)

TESARO to Present at the 2014 Deutsche Bank BioFEST
GlobeNewswire - Tue Nov 25, 4:00PM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST Conference on Tuesday, December 2, 2014 at 4:00 p.m. ET in Boston.
TSRO: 34.36 (+0.32), DB: 30.07 (+0.08)

TESARO to Present at the Nasdaq 31st Investor Program
GlobeNewswire - Tue Nov 25, 7:07AM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Nasdaq 31 Investor Program on Tuesday, December 2, 2014 at 10:15 a.m. GMT in London.
TSRO: 34.36 (+0.32)

Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 2:10PM CST
New data revealed Myriad's (MYGN) myChoice HRD score as an efficient predictor of niraparib sensitivity in patient-derived xenograft models of ovarian cancer
MYGN: 33.02 (-0.41), TSRO: 34.36 (+0.32), ANIP: 55.08 (+1.32), AFFX: 8.90 (+0.10)

TESARO and Myriad Announce Companion Diagnostics Collaboration
GlobeNewswire - Thu Nov 20, 6:45AM CST
TESARO, Inc. (Nasdaq:TSRO) and Myriad Genetics (Nasdaq:MYGN) today announced a collaboration utilizing Myriad's myChoice HRD companion diagnostic (CDx) to identify tumor tissue with a deficiency in homologous recombination. Under the terms of the agreement, TESARO will utilize Myriad's test to enrich the target population for potential responders to niraparib. Myriad will provide testing services and pursue necessary regulatory approvals in support of TESARO's development of niraparib.
MYGN: 33.02 (-0.41), TSRO: 34.36 (+0.32)

'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?
at The Street - Sat Nov 15, 4:00AM CST
The trading panel took a look at gold prices, which climbed 2.3% on Friday, as well as the potential for a pullback in biotech stocks.
AMZN: 295.06 (-11.01), TSRO: 34.36 (+0.32), XBI: 174.87 (-1.02), IBB: 293.67 (-3.99), CELG: 110.09 (-1.79), GILD: 100.46 (-2.70), GLD: 114.95 (+0.56), MCD: 88.72 (+0.26), SLV: 15.08 (-0.39), GDX: 17.10 (-0.24), TWTR: 35.13 (-1.72), AAPL: 106.75 (-1.47), BABA: 105.77 (+1.07)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 4:38PM CST

HK: 1.76 (-0.04), NTES: 98.93 (-0.82), CIG: 4.58 (-0.11), TSRO: 34.36 (+0.32), DDD: 30.05 (+1.67), CLDX: 16.83 (-0.05), SCMP: 12.89 (+0.23), BVN: 9.02 (-0.30), ABGB: 11.97 (-0.05), SSE: 5.10 (+0.31)

TESARO to Present at the Jefferies 2014 Global Healthcare Conference
GlobeNewswire - Wed Nov 12, 7:00AM CST
TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Jefferies 2014 Global Healthcare Conference on Wednesday, November 19, 2014 at 11:20 a.m. GMT in London.
TSRO: 34.36 (+0.32)

TESARO's (TSRO) CEO Lonnie Moulder on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Nov 07, 1:31AM CST

TSRO: 34.36 (+0.32)

Tesaro beats 3Q profit forecasts
Automated Insights - Thu Nov 06, 4:04AM CST
WALTHAM, Mass. (AP) _ Tesaro Inc. (TSRO) on Thursday reported a third-quarter loss of $36.2 million.
TSRO: 34.36 (+0.32)

Tesaro beats by $0.03
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:07PM CST

TSRO: 34.36 (+0.32)

TESARO Announces Third-Quarter 2014 Operating Results
GlobeNewswire - Wed Nov 05, 3:36PM CST
-- Oral Rolapitant New Drug Application (NDA) Accepted for Review by U.S. FDA
TSRO: 34.36 (+0.32)

Tesaro reports November 5
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:34PM CDT

TSRO: 34.36 (+0.32)

Tesaro to Announce Third-Quarter 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:01PM CDT
TESARO, Inc. (Nasdaq:TSRO) will announce its third-quarter 2014 financial results on Wednesday, November 5, 2014, after the close of the U.S. financial markets. TESARO's senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on November 5, 2014 to discuss the Company's results in greater detail.
TSRO: 34.36 (+0.32)

TESARO Announces Closing of $201.25 Million Public Offering of 3.00% Convertible Senior Notes Due 2021, Including Full Exercise of the Underwriters' Option to Purchase Additional Notes
GlobeNewswire - Mon Sep 29, 3:01PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today the closing of its previously announced underwritten public offering of $201.25 million aggregate principal amount of its 3.00% convertible senior notes due 2021 (the "notes" , including the notes issued pursuant to the full exercise of the underwriters' option to purchase up to $26.25 million aggregate principal amount of additional notes on the same terms and conditions. As a result, aggregate net proceeds to TESARO, after deducting the underwriting discount and estimated offering expenses payable by TESARO, will be approximately $194.71 million.
TSRO: 34.36 (+0.32), DB: 30.07 (+0.08)

Weakness Seen in Tesaro, Inc. (TSRO): Stock Tumbles 9.0% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 7:54AM CDT
Make sure to keep a close watch on Tesaro in the near future, and especially on earnings estimates following the recent slump.
TSRO: 34.36 (+0.32)

TESARO Announces Pricing of $175 Million of 3.00% Convertible Senior Notes Due 2021
GlobeNewswire - Tue Sep 23, 9:40PM CDT
TESARO, Inc. (Nasdaq:TSRO) announced today the pricing of $175 million aggregate principal amount of its 3.00% convertible senior notes due 2021 (the "notes" in an underwritten public offering. The size of the offering was increased from the previously announced aggregate principal amount of $165 million. TESARO has granted the underwriters a 30-day option to purchase up to $26.25 million aggregate principal amount of additional notes on the same terms and conditions to cover over-allotments. The offering is expected to close on or about September 29, 2014, subject to customary closing conditions.
TSRO: 34.36 (+0.32), DB: 30.07 (+0.08)

Nasdaq stocks posting largest percentage decreases
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
UBNT: 31.99 (+2.13), TSRO: 34.36 (+0.32), WATT: 7.35 (-0.10), MLAB: 74.58 (+1.57), NVC.TO: 7.20 (+0.05), NVCN: 6.22 (+0.07), PBSK: 14.78 (+0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 161

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 139

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 101

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 28

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 162

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading

Top 5 Most Recently Viewed Articles

Latham Group's Stock Target Rises: A Positive Outlook Ahead

Updated Category News Views 101

Stifel Holds a Positive View on Latham Group Inc. Stifel has recently reaffirmed its Buy rating for Latham Group Inc. (NASDAQ:SWIM) and bumped its price target to $7.00, up from the previous $6.80. This decision is fueled by upcoming investor meetings led by Latham Group's CEO, Scott Rajeski, and CFO, Oliver Gloe. These meetings aim to provide crucial insights into the...

Continue Reading
Keeper Delivers Undeniable Improvements in Account Management

Updated Category News Views 135

Keeper Introduces Instant Account Switching and Passkey Enhancements Keeper Security has recently unveiled a significant upgrade to its mobile applications and browser extension. This update is set to enhance user experience by introducing instant account switching and vital passkey features that make accessing different accounts faster than ever. Seamless Account...

Continue Reading
Sagard Real Estate Ventures into Growth with New Fund

Updated Category News Views 311

Sagard Real Estate Expands Portfolio with New Acquisition Sagard Real Estate, the firm formerly known as EverWest Real Estate Investors, is making waves in the real estate market with its recent acquisition of Vista Imperio. This strategic investment involves a 158-unit suburban garden-style multifamily property, marking a significant step forward for the company in its...

Continue Reading
Celebrating a Decade of Leadership in Complexity and Execution

Updated Category News Views 160

Reflecting on 10 Years of Team of Teams A decade ago, the revolutionary ideas presented in General Stanley McChrystal’s book, Team of Teams: New Rules of Engagement for a Complex World, emerged as a guiding light for leaders navigating complex environments. The principles outlined in this book have proven to be increasingly vital in today’s fast-paced world. Team of...

Continue Reading
Hakeem's Nomination Showcase for FinTech Excellence in 2024

Updated Category News Views 65

Hakeem Earns Recognition at the Singapore FinTech Festival Walee Group is thrilled to announce that its innovative product, Hakeem, has been nominated for the prestigious Singapore FinTech Festival - FinTech Excellence Awards. This accolade highlights the commitment of Walee Financial Services in developing solutions that enhance financial accessibility, particularly for...

Continue Reading